Business Description
Iovance Biotherapeutics is a California-based company that creates cancer treatments by extracting and multiplying a patient's own immune cells to fight tumors. Its lead product, Amtagvi, is approved for adults with advanced melanoma that has not responded to prior treatment, while Proleukin serves patients with melanoma and kidney cancer. The company has a broad pipeline targeting several other cancers, including cervical, lung, and head and neck cancers, and works alongside major research institutions and pharmaceutical partners to advance its therapies.
